This Article Abstract Full Text (PDF) All Versions of this Article: 109/17/2109    most recent 01.CIR.0000125742.65841.8Bv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhu, X.-Y. Articles by Lerman, L. O. Search for Related Content PubMed PubMed Citation Articles by Zhu, X.-Y. Articles by Lerman, L. O. Related Collections Angiogenesis Oxidant stress Mechanism of atherosclerosis/growth factors

(Circulation. 2004;109:2109-2115.)
© 2004 American Heart Association, Inc.

Basic Science Reports

Antioxidant Intervention Attenuates Myocardial Neovascularization in Hypercholesterolemia

Xiang-Yang Zhu, MD, PhD; Martin Rodriguez-Porcel, MD; Michael D. Bentley, PhD; Alejandro R. Chade, MD; Vincenzo Sica, MD; Claudio Napoli, MD, PhD; Noel Caplice, MD, PhD; Erik L. Ritman, MD, PhD; Amir Lerman, MD; Lilach O. Lerman, MD, PhD

From the Department of Internal Medicine, Divisions of Hypertension (X.-Y.Z., A.R.C., L.O.L.) and Cardiovascular Diseases (M.R.-P., N.C., A.L., L.O.L.), and Department of Physiology and Biomedical Engineering (E.R.L.), Mayo Clinic, Rochester, Minn; the Department of Biological Sciences, Minnesota State University, Mankato (M.D.B.); the Departments of Clinical Pathology and Medicine, University of Naples, Italy (V.S., C.N.); and the Department of Cardiology, Xin-hua Hospital, Shanghai, China (X.Z.).

Correspondence to Lilach O. Lerman, MD, PhD, Division of Hypertension, Mayo Clinic College of Medicine, 200 First St, SW, Rochester, MN 55905. E-mail lerman.lilach{at}mayo.edu

Received March 20, 2003; de novo received November 3, 2003; revision received January 9, 2004; accepted January 14, 2004.

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Background— Hypercholesterolemia (HC) and atherosclerosis can elicit oxidative stress, coronary endothelial dysfunction, and myocardial ischemia, which may induce growth-factor expression and lead to myocardial neovascularization. We tested the hypothesis that chronic antioxidant intervention in HC would attenuate neovascularization and preserve the expression of hypoxia-inducible factor (HIF)-1 and vascular endothelial growth factor (VEGF).

Methods and Results— Three groups of pigs (n=6 each) were studied after 12 weeks of normal or 2% HC diet or HC+antioxidant supplementation (100 IU/kg vitamin E and 1 g vitamin C daily). Myocardial samples were scanned ex vivo with a novel 3D micro-CT scanner, and the spatial density and tortuosity of myocardial microvessels were determined in situ. VEGF mRNA, protein levels of VEGF and VEGF receptor-1, HIF-1, nitrotyrosine, and superoxide dismutase (SOD) were determined in myocardial tissue. The HC and HC+antioxidant groups had similar increases in serum cholesterol levels. HC animals showed an increase in subendocardial spatial density of microvessels compared with normal (160.5±11.8 versus 95.3±8.2 vessels/cm², P<0.05), which was normalized in HC+antioxidant (92.5±20.5 vessels/cm², P<0.05 versus HC), as was arteriolar tortuosity. In addition, HC induced upregulation of VEGF, HIF-1, and nitrotyrosine expression and decreased SOD expression and activity, all of which were preserved by antioxidant intervention.

Conclusions— Changes in myocardial microvascular architecture invoked by HC are accompanied by increases in HIF-1 and VEGF expression and attenuated by antioxidant intervention. This underscores a role of increased oxidative stress in modulating myocardial microvascular architecture in early atherogenesis.

Key Words: antioxidant • atherosclerosis • hypercholesterolemia • oxidative stress

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
Hypercholesterolemia (HC) is a major risk factor for atherosclerosis and ischemic heart disease, and even a relatively short exposure may impair myocardial perfusion.¹ We have previously demonstrated that experimental HC was associated with coronary endothelial dysfunction^1,2 that may lead to myocardial ischemia, which was partly mediated by increased oxidative stress³ and was preserved by chronic antioxidant supplementation.⁴ We have also shown that HC induced subendocardial neovascularization, most likely secondary to myocardial ischemia.⁵ However, the mechanism underlying this effect and the potential involvement of increased oxidative stress remained unclear.

A pivotal mechanism by which ischemia induces compensatory angiogenesis is through increased oxidative stress and consequently increased expression of the transcription factor hypoxia-inducible factor (HIF)-1.⁶ HIF-1 may then upregulate the expression of vascular endothelial growth factor (VEGF),⁷ a potent angiogenic growth factor that stimulates endothelial cell proliferation and migration in vitro and angiogenesis in vivo.^8,9 Furthermore, VEGF may be directly upregulated by oxidative stress intermediates such as superoxide radical¹⁰ or peroxynitrite,¹¹ a pro-oxidant formed by the rapid reaction of superoxide and nitric oxide. Indeed, the increase in VEGF bioactivity in human epithelial cells exposed to superoxide can be blocked in vitro by antioxidants.¹⁰ However, it is as yet unknown whether chronic antioxidant supplementation in vivo can decrease VEGF expression and myocardial neovascularization.

Micro–computed tomography (micro-CT) is a novel and powerful imaging technique that permits assessment of the 3D pattern of the microvascular structure in situ¹² and provides a unique and useful means for the study of the spatial distribution and connectivity of microvessels within an organ. We have demonstrated the feasibility of studying myocardial microvascular architecture with micro-CT in pathophysiological states.⁵ Moreover, thanks to its ability to tomographically isolate single intramyocardial arterioles and their branches,¹² it enables determination of microvascular tortuosity, a unique marker of vascular integrity and development of atherosclerosis.¹³

Therefore, this study was designed to test the hypotheses that HC-induced changes in myocardial microvascular architecture (spatial density and tortuosity) would be attenuated during chronic antioxidant supplementation, in association with decreased expression of HIF-1 and VEGF.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
All procedures using animals were reviewed and approved by the Institutional Animal Care and Use Committee. Three groups (n=6 each) of age- and body weight–matched female domestic pigs (55 to 65 kg) were studied after 12 weeks of normal or HC diet (2% cholesterol and 15% lard by weight; TD93296, Harlan Teklad) or HC+dietary antioxidant supplementation (100 IU/kg of vitamin E and 1 g of vitamin C daily). We have previously shown that this combination is effective in decreasing oxidative stress and normalizing myocardial function.^3,4 Plasma lipid profile (Roche) was determined after 12 weeks of diet in all 3 groups. Plasma prostaglandin F₂ isoprostane was determined by electroimmunoassay, as described previously.¹⁴ After euthanasia, the heart was removed for in vitro studies.

Micro-CT Procedure
An intravascular microfil silicone rubber (MV-122, Flow Tech, Inc), a contrast agent that essentially remains in the intravascular compartment, was used to perfuse through the cannulated left anterior descending coronary artery at a flow rate of 0.9 mL/min. A transmural portion of the left ventricular myocardium (2x1x1 cm) was then sectioned, prepared, and scanned as described previously.^5,15,16 Images were digitized for reconstruction of 3D volume images, which consisted of cubic voxels of 20 µm on a side and were displayed at 40 µm cubic voxels for subsequent analysis.⁵

Images analysis was performed with the Analyze software package (Biomedical Imaging Resource). The myocardium was tomographically divided into 3 equal parts, and the data were analyzed in 7 slices obtained at equal intervals from each third. The outer two thirds of the myocardium were considered subepicardium, and the inner third was considered subendocardium.⁵ Using the "Object Counter" computer software, the spatial density of myocardial microvessels (diameters <500 µm) was calculated in each region.^5,16

Using a "connectivity" software that allows for tomographic isolation of a vessel, 1 to 3 intramyocardial arterioles and their branches were tomographically "dissected" in each pig, their branching pattern was visually assessed, and vessel elongation was determined by "Tree Analysis" software. For this purpose, the 3D path distance (total length) and linear distance (shortest distance between end points) of the main branches were calculated, and the elongation factor was calculated by dividing path distance by linear distance.

Spectrophotometry
CuZn-superoxide dismutase (SOD) and Mn-SOD were determined spectrophotometrically as described previously.³ All tissue activities were normalized for protein content by Lowry’s method.

RNA Isolation and cDNA Synthesis
Total RNA was isolated from myocardium by use of the TRIZOL (Invitrogen) method. RNA samples were purified with chloroform and isopropyl alcohol, dissolved in diethyl pyrocarbonate (DEPC)-treated water, and quantified with a spectrophotometer (A₂₆₀). cDNA was synthesized by use of the Invitrogen SuperScrip first-strand synthesis kit as follows: 5 µg total RNA, 1 µL (10 mmol/L) dNTP mix, 2 µL (50 ng/L) random-hexamers primers; the reaction volume was brought to 10 µL with DEPC water and incubated at 65°C for 5 minutes, followed by at least 1 minute of incubation on ice. Then, 2 µL 10x RT buffer, 4 µL (25 mmol/L) MgCl₂, 2 µL (0.1 mol/L) dithiothreitol, 1 µL RnaseOUT, and 1 µL (50 U) of SuperScrip II RT were added into the above reaction mixture and incubated at 25°C for 10 minutes, followed by 42°C for 50 minutes. The reaction was terminated at 70°C for 15 minutes, chilled on ice, and stored at –20°C.

Real-Time Quantitative PCR
To investigate the expression of VEGF mRNA, real-time polymerase chain reaction (PCR) (DNA engine OPTICON, MJ Research) was subsequently performed using the SYBR Green JumpStart Taq ReadyMix kit (Sigma). Briefly, 12.5 µL SYBR Green JumpStart Taq ReadyMix, 0.25 µL internal reference, 0.5 µL primer 5', 0.5 µL primer 3', 1 µL cDNA, and 10.25 µL DEPC water reached 25 µL final reaction volume. The porcine gene–specific sequence of VEGF primer used was upper, 5'-ACCAAGGCCAGCACATAG-GAGAGA-3' and lower, 5'-CTCGCTCTATCTTTCTTTGGTCTG-3'. The temperature profile included denaturation at 95°C for 3 minutes, followed by 45 cycles of denaturation at 95°C for 40 seconds, 60 seconds at 60°C annealing, and elongation with optics on for fluorescence monitoring. The relative amount of VEGF mRNA was normalized to an internal control GAPDH and relative to a calibrator (normal), calculated by 2^–CT.¹⁷ The sequence of the GAPDH primer was upper, 5'-GGGCATGAACCATGAGAAGT-3' and lower, 5'-GTCTTCTGGGTGGCAGTGAT-3'.

Western Blotting
Equal protein of myocardial homogenate was dissolved in SDS-polyacrylamide gels (10% or 15%) under reducing conditions (0.1 mol/L fresh dithiothreitol in sample buffer) and electrophoretically transferred onto polyvinylidene difluoride membrane (Bio-Rad).¹⁸ Membranes were blocked for 1 hour in Tris-buffered saline–Tween (TBST)/5% nonfat milk and incubated overnight at 4°C with antibodies against the 2 isoforms of SOD: Mn-SOD (1:200, Chemicon International) and CuZn-SOD (1:500, Santa Cruz Biotechnology). Antibodies against HIF-1 (1:200, Santa Cruz Biotechnology) and nitrotyrosine (1:500, Cayman Chemical) were also used. After washing with TBST, the membranes were incubated for 1 hour with horseradish peroxidase–linked anti-rabbit or anti-mouse antibody (1:5000, Amersham Pharmacia Biotech) in TBST/5% milk, and proteins were visualized by electrochemiluminescence. In additional experiments, to demonstrate specificity for nitrotyrosine, the membrane was incubated with 10 mmol/L dithionite (Sigma) for 1 hour at room temperature to remove tyrosine nitration.¹⁹ ß-Actin (1:1000, Sigma) was used as the loading control.

ELISA Assay
VEGF and VEGF receptor-1 (Flt-1) protein levels were determined by ELISA (Human VEGF and Flt-1 kits, R&D Systems). Briefly, 100 µL of standards or serum was added to the wells of microplate precoated with a monoclonal antibody specific for human VEGF165 or Flt-1 and incubated for 2 hours at room temperature. The anti-VEGF antibody shows cross-reactivity with porcine, and validation studies have shown that this kit provides reliable measurement of VEGF concentration.²⁰ After any unbound substances had been washed away, an enzyme-linked polyclonal antibody against VEGF or Flt-1 conjugated to horseradish peroxidase was added to the wells and incubated for 2 hours. After a wash, 200 µL of substrate solution was added to the wells and incubated for 30 minutes, and 50 µL of stop solution was then added for color development. The optical density of each well was determined with a microplate reader at 450 nm.

Statistical Analysis
Continuous data are expressed as mean±SEM. Multiple group comparisons used ANOVA, followed by unpaired t test, when applicable. Statistical significance was accepted at a value of P0.05. Protein expression was assessed relative to the loading control (actin) and expressed as ratio.

	Results

Top Abstract Introduction Methods Results Discussion References

 
After 12 weeks of HC diet, serum total and LDL cholesterol levels in HC and HC+antioxidant pigs were significantly and similarly higher than normal, whereas triglycerides remained unchanged (Table 1).

View this table: [in this window] [in a new window]   TABLE 1. Systemic and Myocardial Tissue Characteristics of Normal, Hypercholesterolemic (HC), and HC+Antioxidant Pigs

Intramyocardial Microvascular Architecture and Number
The vessels appeared more densely packed in HC than in normal hearts (Figure 1, top). Moreover, tomographically isolated microvascular trees in HC showed more ramifications and appeared more tortuous than in normal hearts (Figure 1, bottom). All of these alterations were preserved by antioxidant intervention. Quantitatively, the spatial density of small microvessels (<200 µm) was significantly higher in HC than normal (Table 2), an increase that was more pronounced in the subendocardium (ANOVA, P=0.007), and was normalized in HC+antioxidants (Table 2).

View larger version (66K): [in this window] [in a new window]   Figure 1. Representative 3D tomographic images (displayed at 40-µm voxel size) obtained from myocardium in normal, HC, and HC+antioxidant pigs. Top, Transmural myocardium. Bottom, Tomographically isolated transmural arterioles, showing in HC increased sprouting, which was prevented by antioxidant supplementation.

View this table: [in this window] [in a new window]   TABLE 2. Spatial Density (vessels/cm2) and Tortuosity (Elongation Factor, Dimensionless) of Myocardial Microvessels in Normal, Hypercholesterolemic (HC), and HC+Antioxidant Pigs

Redox Status
Isoprostane levels were higher in HC, suggesting an increase in oxidative stress, but were significantly decreased in HC+antioxidant (Table 1). Compared with normal, HC pigs also showed decreased activity of both CuZn-SOD and Mn-SOD, implying blunted radical scavenging activity that remained attenuated in HC+antioxidant (Table 1). Conversely, protein expression of CuZn-SOD but not Mn-SOD was decreased in HC and also remained attenuated in HC+antioxidant (Figure 2). HC myocardium had increased immunoreactivity of nitrotyrosine, implying greater abundance of superoxide and interaction with nitric oxide, which was reduced in HC+antioxidant (Figure 3). Nitrotyrosine immunoactivity was abolished by pretreatment with dithionite, demonstrating the specificity of the method for nitrotyrosine.

View larger version (19K): [in this window] [in a new window]   Figure 2. Myocardial densitometry and representative immunoblots of 2 isoforms of SOD, Mn-SOD (right; MW, 24 kDa) and CuZn-SOD (left; MW, 15 kDa) in normal, HC, and HC+antioxidant pigs (n=6 each group). *P<0.05 vs normal.

View larger version (48K): [in this window] [in a new window]   Figure 3. Top, Myocardial densitometry and representative immunoblots of nitrotyrosine in normal, HC, and HC+antioxidant pigs. Several bands are evident because of nitration of tyrosine in various cellular proteins. Bottom, Similar Western blotting obtained after dithionite treatment, which blocks tyrosine nitration. *P<0.05 vs normal (n=6 each group).

Myocardial Tissue
HC pigs showed increased expression of HIF-1 protein (Figure 4), which may reflect myocardial tissue hypoxia. VEGF mRNA and protein were also increased in HC (Figure 5), whereas the expression of its receptor Flt-1 remained unchanged (Table 1). All these parameters were preserved in HC animals that had been chronically supplemented with antioxidants (Figures 4 and 5).

View larger version (38K): [in this window] [in a new window]   Figure 4. Myocardial densitometry and representative immunoblots of HIF-1 (MW, 135 kDa) in normal, HC, and HC+antioxidant pigs (n=6 each group). *P<0.05 vs normal.

View larger version (63K): [in this window] [in a new window]   Figure 5. VEGF mRNA and protein expression in normal, HC, and HC+antioxidant pigs. Total myocardial mRNA was reverse-transcribed into cDNA and amplified with VEGF and GAPDH specific primers. GAPDH was used as an internal control. Top, PCR products were of predicted size: VEGF, 79 bp; GAPDH, 162 bp. Bottom left, Real-time PCR results were quantified and expressed as percent change in copy numbers compared with normal group; bottom right, ELISA measurement of myocardial VEGF protein level. *P<0.05 vs normal.

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
This study demonstrates that chronic blockade of the oxidative-stress cascade blunts HC-induced alterations in intramyocardial microvascular architecture and attenuates the expression of HIF-1 and VEGF.

Hypercholesterolemia is a major risk factor for coronary heart disease and may lead to coronary endothelial dysfunction and myocardial perfusion abnormalities.³ Furthermore, we have previously shown that HC is associated with microvascular neovascularization,⁵ possibly because of an increased subendocardial propensity for ischemia in microvascular disease. The present study demonstrates, for the first time, that diet-induced HC is also associated with increased vascular tortuosity. Increases in vascular tortuosity have been described previously in retinal, peripheral, and coronary arteries in association with advanced atherosclerosis,^13,21 which might result from upregulation of elastolytic enzymes, breakdown of elastin fibers,²² and consequent vascular elongation and coiling, and their decrease by antioxidants in our study suggests a role for oxidative stress in this mechanism.²³

The mechanisms by which HC induces neovascularization may be multifactorial. Experimental HC is known to increase oxidative stress and inflammation, with consequent release of free radicals, cytokines, and growth factors.^24,25 Hence, decreased SOD bioactivity and increased myocardial nitrotyrosine immunoreactivity in our HC pigs reflect attenuated scavenging activity and increased abundance of superoxide anion associated with a pro-oxidant shift. Both increased formation of superoxide radical²⁶ and peroxynitrite^11,27 further impair SOD activity and thereby lead to a vicious cycle of increased oxidative stress. Notably, decreased Mn-SOD enzymatic bioactivity is not necessarily accompanied by decreased Mn-SOD protein expression, which can in fact be paradoxically increased.²⁸ Furthermore, the change in SOD bioactivity may be cell-type– and organ-specific,²⁹ may show temporal variation during development of oxidative stress,³⁰ and may depend on disease type, duration, and severity.³¹ In this study, although the activity of Mn-SOD was significantly decreased, its protein expression was not different from that in normal animals, supporting dissociation between the expression and functionality of this isoform. Indeed, disparate changes in the expression and function of these isoforms may be noted in disease states and reflect the diverse roles of this scavenger system.

This increase in oxidative stress has been shown to increase expression of HIF-1,^26,32 which in turn induces VEGF expression.³² Furthermore, oxygen-derived and other radicals are increasingly recognized as direct signaling mediators both upstream and downstream^33,34 to VEGF, and oxidized LDL per se can also directly increase VEGF expression.³⁵ Therefore, increased oxidative stress may modulate neovascularization via several different pathways.³⁶ Among these, hypoxia and increased VEGF expression are recognized as particularly potent angiogenic stimuli.³² Accordingly, this study shows that both VEGF mRNA and protein were increased in HC and normalized by antioxidant intervention. Although a decrease in VEGF protein expression could have been secondary to antioxidant-induced increased Flt-1 expression and VEGF binding, we observed that Flt-1 expression was similar in normal, HC, and HC+antioxidant pigs. These results support a direct effect of HC and antioxidants on the VEGF molecule rather than on its receptor. The present study also shows that chronic blockade of the oxidative stress not only preserved the expression of HIF-1 and VEGF but also normalized myocardial microvascular architecture in experimental HC. These results suggest an association between oxidative stress and neovascularization, which may be mediated in part via HIF-1 and VEGF. Antioxidants may attenuate this cascade at multiple points, and their beneficial effect may be a result of decreased LDL oxidation, inflammation, and/or redox-sensitive mechanisms and improved endothelial function and myocardial perfusion. Notably, we have previously shown that decreased myocardial perfusion in HC was inversely correlated with a concurrent increase in myocardial microvascular permeability, conceivably reflecting upregulation of VEGF, a potent vascular permeability factor. Remarkably, changes in microvascular permeability were not only normalized by use of antioxidant vitamin supplementation but significantly and inversely correlated with plasma concentrations of vitamins E and C and with tissue levels of vitamin E and Mn-SOD.³ These observations provide strong support to the relationship between myocardial ischemia (and thereby HIF-1), VEGF, and increased oxidative stress.

The increase in vessel formation in HC might be a compensatory response aimed at sustaining myocardial perfusion. This response is probably only partly successful, because the newly formed vessels show abnormal function, and myocardial response to challenge remains impaired in HC.³ The ability of antioxidants to improve both myocardial microvascular architecture (as shown in the present study) and function (as we have shown previously³) suggests that rather than interfering with a compensatory process, antioxidants blunt the upstream pathological stimulus (eg, ischemia) that triggers adaptive structural changes in HC. Furthermore, this effect may be dose-dependent, similar to HMG-CoA reductase inhibitors, which have biphasic effects on angiogenesis.³⁷ Indeed, the variable results of antioxidant vitamin intervention observed in clinical studies^38–40 are most likely related to differences in study population, the duration, dose, and type of supplements, and outcome measures. Nevertheless, this capability of antioxidants to attenuate angiogenesis should be taken into consideration during design of therapeutic angiogenesis approaches.

Microvascular changes may occur during growth and maturation in the normal porcine heart. However, our previous studies showed that pigs similar to those used in the present studies have mature vasculature.⁴¹ In addition, all the pigs used in the present study were of similar age and body weight, arguing against interference of age- or weight-related changes with our results. Furthermore, our model of 12-week diet-induced HC does not induce left ventricular hypertrophy.⁴² A decrease in microvascular spatial density observed in antioxidant-treated animals may hypothetically be secondary to vasoconstriction or interstitial expansion, but these are unlikely to be induced by antioxidants, because our samples are allowed full relaxation before contrast injection.⁵

Thus, we observed that increased HIF-1 and VEGF expression induced by HC, with consequent changes in myocardial architecture, have been preserved by antioxidant intervention. Our study indicates that increased oxidative stress contributes to myocardial neovascularization in HC and implies a novel role for antioxidants in early atherogenesis.

	Acknowledgments

 
This study was supported in part by the National Institutes of Health, grant numbers HL-63282 and EB000305, and the American Heart Association. Dr Zhu also received stipend support from Xinhua Hospital, Shanghai, China.

	References

Top Abstract Introduction Methods Results Discussion References

 
1. Napoli C, Lerman LO. Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia. Mayo Clin Proc. 2001; 76: 619–631.[Abstract]

2. Wilson SH, Simari RD, Best PJ, et al. Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering. Arterioscler Thromb Vasc Biol. 2001; 21: 122–128.[Abstract/Free Full Text]

3. Rodriguez-Porcel M, Lerman A, Best PJ, et al. Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity. J Am Coll Cardiol. 2001; 37: 608–615.[Abstract/Free Full Text]

4. Rodriguez-Porcel M, Lerman LO, Holmes DR Jr, et al. Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs. Cardiovasc Res. 2002; 53: 1010–1018.[Abstract/Free Full Text]

5. Rodriguez-Porcel M, Lerman A, Ritman EL, et al. Altered myocardial microvascular 3D architecture in experimental hypercholesterolemia. Circulation. 2000; 102: 2028–2030.[Abstract/Free Full Text]

6. Gao N, Ding M, Zheng JZ, et al. Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3- kinase/Akt pathway and reactive oxygen species. J Biol Chem. 2002; 277: 31963–31971.[Abstract/Free Full Text]

7. Chandel NS, Maltepe E, Goldwasser E, et al. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A. 1998; 95: 11715–11720.[Abstract/Free Full Text]

8. Shibuya M. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct Funct. 2001; 26: 25–35.[CrossRef][Medline] [Order article via Infotrieve]

9. Li J, Brown LF, Hibberd MG, et al. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol. 1996; 270: H1803–H1811.[Medline] [Order article via Infotrieve]

10. Kuroki M, Voest EE, Amano S, et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest. 1996; 98: 1667–1675.[Medline] [Order article via Infotrieve]

11. Borkowski A, Younge BR, Szweda L, et al. Reactive nitrogen intermediates in giant cell arteritis: selective nitration of neocapillaries. Am J Pathol. 2002; 161: 115–123.[Abstract/Free Full Text]

12. Jorgensen SM, Demirkaya O, Ritman EL. Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with x-ray micro-CT. Am J Physiol. 1998; 275: H1103–H1114.[Medline] [Order article via Infotrieve]

13. Smedby O, Bergstrand L. Tortuosity and atherosclerosis in the femoral artery: what is cause and what is effect? Ann Biomed Eng. 1996; 24: 474–480.[Medline] [Order article via Infotrieve]

14. Krier JD, Rodriguez-Porcel M, Best PJ, et al. Vascular responses in vivo to 8-epi PGF(2alpha) in normal and hypercholesterolemic pigs. Am J Physiol. 2002; 283: R303–R308.

15. Herrmann J, Lerman LO, Rodriguez-Porcel M, et al. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res. 2001; 51: 762–766.[Abstract/Free Full Text]

16. Bentley MD, Rodriguez-Porcel M, Lerman A, et al. Enhanced renal cortical vascularization in experimental hypercholesterolemia. Kidney Int. 2002; 61: 1056–1063.[CrossRef][Medline] [Order article via Infotrieve]

17. Poon RT, Lau CP, Cheung ST, et al. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma. Cancer Res. 2003; 63: 3121–3126.[Abstract/Free Full Text]

18. Hinson JA, Michael SL, Ault SG, et al. Western blot analysis for nitrotyrosine protein adducts in livers of saline-treated and acetaminophen-treated mice. Toxicol Sci. 2000; 53: 467–473.[Abstract/Free Full Text]

19. Miyagi M, Sakaguchi H, Darrow RM, et al. Evidence that light modulates protein nitration in rat retina. Mol Cell Proteomics. 2002; 1: 293–303.[Abstract/Free Full Text]

20. Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998; 97: 1114–1123.[Abstract/Free Full Text]

21. Hutchins GM, Miner MM, Bulkley BH. Tortuosity as an index of the age and diameter increase of coronary collateral vessels in patients after acute myocardial infarction. Am J Cardiol. 1978; 41: 210–215.[CrossRef][Medline] [Order article via Infotrieve]

22. Dollery CM, Owen CA, Sukhova GK, et al. Neutrophil elastase in human atherosclerotic plaques: production by macrophages. Circulation. 2003; 107: 2829–2836.[Abstract/Free Full Text]

23. Hayashi A, Ryu A, Suzuki T, et al. In vitro degradation of tropoelastin by reactive oxygen species. Arch Dermatol Res. 1998; 290: 497–500.[CrossRef][Medline] [Order article via Infotrieve]

24. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340: 115–126.[Free Full Text]

25. Bendeck MP. Mining the myocardium with macrophage drills: a novel mechanism for revascularization. Circ Res. 2000; 87: 341–343.[Free Full Text]

26. Chandel NS, McClintock DS, Feliciano CE, et al. Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O₂ sensing. J Biol Chem. 2000; 275: 25130–25138.[Abstract/Free Full Text]

27. MacMillan-Crow LA, Crow JP, Thompson JA. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry. 1998; 37: 1613–1622.[CrossRef][Medline] [Order article via Infotrieve]

28. MacMillan-Crow LA, Crow JP, Kerby JD, et al. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci U S A. 1996; 93: 11853–11858.[Abstract/Free Full Text]

29. Kinscherf R, Kohler C, Kreuter C, et al. Hypercholesterolemia increases manganese superoxide dismutase immunoreactive macrophages in myocardium. Histochem Cell Biol. 1995; 104: 295–300.[CrossRef][Medline] [Order article via Infotrieve]

30. Kakkar R, Mantha SV, Kalra J, et al. Time course study of oxidative stress in aorta and heart of diabetic rat. Clin Sci (Lond). 1996; 91: 441–448.[Medline] [Order article via Infotrieve]

31. t Hoen PA, Van der Lans CA, Van Eck M, et al. Aorta of apoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. Circ Res. 2003; 93: 262–269.[Abstract/Free Full Text]

32. Duyndam MC, Hulscher TM, Fontijn D, et al. Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite. J Biol Chem. 2001; 276: 48066–48076.[Abstract/Free Full Text]

33. Marumo T, Schini-Kerth VB, Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes. 1999; 48: 1131–1137.[Abstract]

34. Colavitti R, Pani G, Bedogni B, et al. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J Biol Chem. 2002; 277: 3101–3108.[Abstract/Free Full Text]

35. Salomonsson L, Pettersson S, Englund MC, et al. Post-transcriptional regulation of VEGF expression by oxidised LDL in human macrophages. Eur J Clin Invest. 2002; 32: 767–774.[CrossRef][Medline] [Order article via Infotrieve]

36. Maulik N, Das DK. Redox signaling in vascular angiogenesis. Free Radic Biol Med. 2002; 33: 1047–1060.[CrossRef][Medline] [Order article via Infotrieve]

37. Weis M, Heeschen C, Glassford AJ, et al. Statins have biphasic effects on angiogenesis. Circulation. 2002; 105: 739–745.[Abstract/Free Full Text]

38. Salonen RM, Nyyssonen K, Kaikkonen J, et al. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation. 2003; 107: 947–953.[Abstract/Free Full Text]

39. Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000; 342: 154–160.[Abstract/Free Full Text]

40. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996; 347: 781–786.[CrossRef][Medline] [Order article via Infotrieve]

41. Mohlenkamp S, Behrenbeck TR, Lerman A, et al. Coronary microvascular functional reserve: quantification of long-term changes with electron-beam CT preliminary results in a porcine model. Radiology. 2001; 221: 229–236.[Abstract/Free Full Text]

42. Rodriguez-Porcel M, Lerman A, Herrmann J, et al. Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature. Cardiovasc Res. 2003; 58: 213–221.[Abstract/Free Full Text]

This article has been cited by other articles:

				R. Iliescu, S. R. Fernandez, S. Kelsen, C. Maric, and A. R. Chade Role of renal microcirculation in experimental renovascular disease Nephrol. Dial. Transplant., November 23, 2009; (2009) gfp605v1. [Abstract] [Full Text] [PDF]

				J. Lin, X. Zhu, A. R. Chade, K. L. Jordan, R. Lavi, E. Daghini, M. E. Gibson, A. Guglielmotti, A. Lerman, and L. O. Lerman Monocyte Chemoattractant Proteins Mediate Myocardial Microvascular Dysfunction in Swine Renovascular Hypertension Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1810 - 1816. [Abstract] [Full Text] [PDF]

				H. Zhao, Y. Wang, Y. Wu, X. Li, G. Yang, X. Ma, R. Zhao, and H. Liu Hyperlipidemia does not prevent the cardioprotection by postconditioning against myocardial ischemia/reperfusion injury and the involvement of hypoxia inducible factor-1{alpha} upregulation Acta Biochim Biophys Sin, September 1, 2009; 41(9): 745 - 753. [Abstract] [Full Text] [PDF]

				X.-Y. Zhu, E. Daghini, A. R. Chade, D. Versari, J. D. Krier, K. B. Textor, A. Lerman, and L. O. Lerman Myocardial microvascular function during acute coronary artery stenosis: effect of hypertension and hypercholesterolaemia Cardiovasc Res, July 15, 2009; 83(2): 371 - 380. [Abstract] [Full Text] [PDF]

				A. R. Chade, X. Zhu, R. Lavi, J. D. Krier, S. Pislaru, R. D. Simari, C. Napoli, A. Lerman, and L. O. Lerman Endothelial Progenitor Cells Restore Renal Function in Chronic Experimental Renovascular Disease Circulation, February 3, 2009; 119(4): 547 - 557. [Abstract] [Full Text] [PDF]

				A. R. Chade, J. D. Krier, O. Galili, A. Lerman, and L. O. Lerman Role of Renal Cortical Neovascularization in Experimental Hypercholesterolemia Hypertension, October 1, 2007; 50(4): 729 - 736. [Abstract] [Full Text] [PDF]

				X.-Y. Zhu, M. D. Bentley, A. R. Chade, E. L. Ritman, A. Lerman, and L. O. Lerman Early changes in coronary artery wall structure detected by microcomputed tomography in experimental hypercholesterolemia Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1997 - H2003. [Abstract] [Full Text] [PDF]

				E. Daghini, X.-Y. Zhu, D. Versari, M. D. Bentley, C. Napoli, A. Lerman, and L. O. Lerman Antioxidant vitamins induce angiogenesis in the normal pig kidney Am J Physiol Renal Physiol, July 1, 2007; 293(1): F371 - F381. [Abstract] [Full Text] [PDF]

				D. Mannheim, D. Versari, E. Daghini, M. Gossl, O. Galili, A. Chade, V. S. Rajkumar, E. L. Ritman, L. O. Lerman, and A. Lerman Impaired myocardial perfusion reserve in experimental hypercholesterolemia is independent of myocardial neovascularization Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2449 - H2458. [Abstract] [Full Text] [PDF]

				X.-Y. Zhu, E. Daghini, A. R. Chade, M. Rodriguez-Porcel, C. Napoli, A. Lerman, and L. O. Lerman Role of Oxidative Stress in Remodeling of the Myocardial Microcirculation in Hypertension Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1746 - 1752. [Abstract] [Full Text] [PDF]

				A. R. Chade, X. Zhu, O. P. Mushin, C. Napoli, A. Lerman, and L. O. Lerman Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia FASEB J, August 1, 2006; 20(10): 1706 - 1708. [Abstract] [Full Text] [PDF]

				B. Gigante, G. Morlino, M. T. Gentile, M. G. Persico, and S. De Falco Plgf-/-eNos-/- mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia FASEB J, May 1, 2006; 20(7): 970 - 972. [Abstract] [Full Text] [PDF]

				M. Rodriguez-Porcel, X.-Y. Zhu, A. R. Chade, B. Amores-Arriaga, N. M. Caplice, E. L. Ritman, A. Lerman, and L. O. Lerman Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H978 - H984. [Abstract] [Full Text] [PDF]

				D. Versari, E. Daghini, M. Rodriguez-Porcel, K. Sattler, O. Galili, K. Pilarczyk, C. Napoli, L. O. Lerman, and A. Lerman Chronic Antioxidant Supplementation Impairs Coronary Endothelial Function and Myocardial Perfusion in Normal Pigs Hypertension, March 1, 2006; 47(3): 475 - 481. [Abstract] [Full Text] [PDF]

				A. C. Langheinrich, A. Michniewicz, D. G. Sedding, G. Walker, P. E. Beighley, W. S. Rau, R. M. Bohle, and E. L. Ritman Correlation of Vasa Vasorum Neovascularization and Plaque Progression in Aortas of Apolipoprotein E-/-/Low-Density Lipoprotein-/- Double Knockout Mice Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 347 - 352. [Abstract] [Full Text] [PDF]

				A. R. Chade, O. P. Mushin, X. Zhu, M. Rodriguez-Porcel, J. P. Grande, S. C. Textor, A. Lerman, and L. O. Lerman Pathways of Renal Fibrosis and Modulation of Matrix Turnover in Experimental Hypercholesterolemia Hypertension, October 1, 2005; 46(4): 772 - 779. [Abstract] [Full Text] [PDF]

				D. Hilfiker-Kleiner, A. Hilfiker, K. Kaminski, A. Schaefer, J.-K. Park, K. Michel, A. Quint, M. Yaniv, J. B. Weitzman, and H. Drexler Lack of JunD Promotes Pressure Overload-Induced Apoptosis, Hypertrophic Growth, and Angiogenesis in the Heart Circulation, September 6, 2005; 112(10): 1470 - 1477. [Abstract] [Full Text] [PDF]

				A. R. Chade, J. Herrmann, X. Zhu, J. D. Krier, A. Lerman, and L. O. Lerman Effects of Proteasome Inhibition on the Kidney in Experimental Hypercholesterolemia J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1005 - 1012. [Abstract] [Full Text] [PDF]

				J. Herrmann, S. Samee, A. Chade, M. R. Porcel, L. O. Lerman, and A. Lerman Differential Effect of Experimental Hypertension and Hypercholesterolemia on Adventitial Remodeling Arterioscler Thromb Vasc Biol, February 1, 2005; 25(2): 447 - 453. [Abstract] [Full Text] [PDF]

				K. J.E. Sattler, J. E. Woodrum, O. Galili, M. Olson, S. Samee, F. B. Meyer, X.-Y. Zhu, L. O. Lerman, and A. Lerman Concurrent Treatment With Renin-Angiotensin System Blockers and Acetylsalicylic Acid Reduces Nuclear Factor {kappa}B Activation and C-Reactive Protein Expression in Human Carotid Artery Plaques Stroke, January 1, 2005; 36(1): 14 - 20. [Abstract] [Full Text] [PDF]

				X.-Y. Zhu, A. R. Chade, M. Rodriguez-Porcel, M. D. Bentley, E. L. Ritman, A. Lerman, and L. O. Lerman Cortical Microvascular Remodeling in the Stenotic Kidney: Role of Increased Oxidative Stress Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1854 - 1859. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 109/17/2109    most recent 01.CIR.0000125742.65841.8Bv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhu, X.-Y. Articles by Lerman, L. O. Search for Related Content PubMed PubMed Citation Articles by Zhu, X.-Y. Articles by Lerman, L. O. Related Collections Angiogenesis Oxidant stress Mechanism of atherosclerosis/growth factors